Loris Eye Drops
Natural health product licensed in Canada
- Licence holder
- Lernapharm (Loris) Inc.
- NPN or DIN-HM
- 80093242
- Status
- Active licence
- Licence date
- 10 July 2019
- Revision date
- Not provided
- Form
- Gouttes ophtalmiques
- Route of administration
- Ophthalmique
- Application type
- Générale (non traditionelle)
Oral dose analysis does not apply without an established exclusively oral route.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Nonoxynol-9, Acide citrique anhydre, Glycérol, Phosphate de disodium anhydre, Chlorure de sodium, Eau, Hydroxyde de sodium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Infants, children and adolescents | Not specified | minimum: 1 Goutte(s) ; maximum: 2 Goutte(s) | 1 Tous les jours |
| Adultes | minimum: 19 years | minimum: 1 Goutte(s) ; maximum: 2 Goutte(s) | 1 Tous les jours |
Uses authorised in Canada
For conjunctival antisepsis prior to ocular surgery to support postoperative infection control.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
For Ophthalmic use Only. Do not use with other medicines that are intended for ocular administration, including other antimicrobial agents, because of the potential for antagonism or inactivation of povidone iodine. Concomitant use with formulations containing mercury-based preservatives (which may be present in some ophthalmicmedicines) must be avoided due to the risk of formation of caustic compounds.
- Contre-indications
Do not use if you are hypersensitive to iodated povidone, to iodine or to any of the non-medicinal ingredients. Do not use concomitantly with topical ophthalmological formulations containing mercury-based preservatives. Do not use in pre-term neonates or those weighing less than 1.5 kg.
Source
Official Health Canada record, licence 80093242
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.